TY - JOUR
T1 - Smoking, Alcohol, and Biliary Tract Cancer Risk
T2 - A Pooling Project of 26 Prospective Studies
AU - McGee, Emma E.
AU - Jackson, Sarah S.
AU - Petrick, Jessica L.
AU - Van Dyke, Alison L.
AU - Adami, Hans Olov
AU - Albanes, Demetrius
AU - Andreotti, Gabriella
AU - Beane-Freeman, Laura E.
AU - de Gonzalez, Amy Berrington
AU - Buring, Julie E.
AU - Chan, Andrew T.
AU - Chen, Yu
AU - Fraser, Gary E.
AU - Freedman, Neal D.
AU - Gao, Yu Tang
AU - Gapstur, Susan M.
AU - Gaziano, J. Michael
AU - Giles, Graham G.
AU - Grant, Eric J.
AU - Grodstein, Francine
AU - Hartge, Patricia
AU - Jenab, Mazda
AU - Kitahara, Cari M.
AU - Knutsen, Synnove F.
AU - Koh, Woon Puay
AU - Larsson, Susanna C.
AU - Lee, I. Min
AU - Liao, Linda M.
AU - Luo, Juhua
AU - Milne, Roger L.
AU - Monroe, Kristine R.
AU - Neuhouser, Marian L.
AU - O’Brien, Katie M.
AU - Peters, Ulrike
AU - Poynter, Jenny N.
AU - Purdue, Mark P.
AU - Robien, Kim
AU - Sandler, Dale P.
AU - Sawada, Norie
AU - Schairer, Catherine
AU - Sesso, Howard D.
AU - Simon, Tracey G.
AU - Sinha, Rashmi
AU - Stolzenberg-Solomon, Rachael
AU - Tsugane, Shoichiro
AU - Wang, Renwei
AU - Weiderpass, Elisabete
AU - Weinstein, Stephanie J.
AU - White, Emily
AU - Wolk, Alicja
AU - Yuan, Jian Min
AU - Zeleniuch-Jacquotte, Anne
AU - Zhang, Xuehong
AU - Zhu, Bin
AU - McGlynn, Katherine A.
AU - Campbell, Peter T.
AU - Koshiol, Jill
N1 - Publisher Copyright:
© 2019 Oxford University Press. All rights reserved.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Background: Tobacco and alcohol are well-established risk factors for numerous cancers, yet their relationship to biliary tract cancers remains unclear. Methods: We pooled data from 26 prospective studies to evaluate associations of cigarette smoking and alcohol consumption with biliary tract cancer risk. Study-specific hazard ratios (HRs) and 95% confidence intervals (CIs) for associations with smoking and alcohol consumption were calculated. Random-effects meta-analysis produced summary estimates. All statistical tests were two-sided. Results: Over a period of 38 369 156 person-years of follow-up, 1391 gallbladder, 758 intrahepatic bile duct, 1208 extrahepatic bile duct, and 623 ampulla of Vater cancer cases were identified. Ever, former, and current smoking were associated with increased extrahepatic bile duct and ampulla of Vater cancers risk (eg, current vs never smokers HR ¼ 1.69, 95% CI ¼ 1.34 to 2.13 and 2.22, 95% CI ¼ 1.69 to 2.92, respectively), with dose-response effects for smoking pack-years, duration, and intensity (all Ptrend < .01). Current smoking and smoking intensity were also associated with intrahepatic bile duct cancer (eg, >40 cigarettes per day vs never smokers HR ¼ 2.15, 95 % CI ¼ 1.15 to 4.00; Ptrend ¼ .001). No convincing association was observed between smoking and gallbladder cancer. Alcohol consumption was only associated with intrahepatic bile duct cancer, with increased risk for individuals consuming five or more vs zero drinks per day (HR ¼ 2.35, 95%CI ¼ 1.46 to 3.78; Ptrend ¼ .04). There was evidence of statistical heterogeneity among several cancer sites, particularly between gallbladder cancer and the other biliary tract cancers. Conclusions: Smoking appears to increase the risk of developing all biliary tract cancers except gallbladder cancer. Alcohol may increase the risk of intrahepatic bile duct cancer. Findings highlight etiologic heterogeneity across the biliary tract.
AB - Background: Tobacco and alcohol are well-established risk factors for numerous cancers, yet their relationship to biliary tract cancers remains unclear. Methods: We pooled data from 26 prospective studies to evaluate associations of cigarette smoking and alcohol consumption with biliary tract cancer risk. Study-specific hazard ratios (HRs) and 95% confidence intervals (CIs) for associations with smoking and alcohol consumption were calculated. Random-effects meta-analysis produced summary estimates. All statistical tests were two-sided. Results: Over a period of 38 369 156 person-years of follow-up, 1391 gallbladder, 758 intrahepatic bile duct, 1208 extrahepatic bile duct, and 623 ampulla of Vater cancer cases were identified. Ever, former, and current smoking were associated with increased extrahepatic bile duct and ampulla of Vater cancers risk (eg, current vs never smokers HR ¼ 1.69, 95% CI ¼ 1.34 to 2.13 and 2.22, 95% CI ¼ 1.69 to 2.92, respectively), with dose-response effects for smoking pack-years, duration, and intensity (all Ptrend < .01). Current smoking and smoking intensity were also associated with intrahepatic bile duct cancer (eg, >40 cigarettes per day vs never smokers HR ¼ 2.15, 95 % CI ¼ 1.15 to 4.00; Ptrend ¼ .001). No convincing association was observed between smoking and gallbladder cancer. Alcohol consumption was only associated with intrahepatic bile duct cancer, with increased risk for individuals consuming five or more vs zero drinks per day (HR ¼ 2.35, 95%CI ¼ 1.46 to 3.78; Ptrend ¼ .04). There was evidence of statistical heterogeneity among several cancer sites, particularly between gallbladder cancer and the other biliary tract cancers. Conclusions: Smoking appears to increase the risk of developing all biliary tract cancers except gallbladder cancer. Alcohol may increase the risk of intrahepatic bile duct cancer. Findings highlight etiologic heterogeneity across the biliary tract.
KW - Confidence Intervals
KW - Prospective Studies
KW - Age Factors
KW - Bile Duct Neoplasms/epidemiology
KW - Humans
KW - Middle Aged
KW - Non-Smokers
KW - Risk Factors
KW - Common Bile Duct Neoplasms/epidemiology
KW - Proportional Hazards Models
KW - Male
KW - Smoking/adverse effects
KW - Ampulla of Vater
KW - Gallbladder Neoplasms/epidemiology
KW - Bile Ducts, Extrahepatic
KW - Smokers/statistics & numerical data
KW - Sex Factors
KW - Adult
KW - Bile Ducts, Intrahepatic
KW - Female
KW - Aged
KW - Ex-Smokers
KW - Alcohol Drinking/adverse effects
UR - https://www.scopus.com/pages/publications/85072023428
UR - https://www.scopus.com/pages/publications/85072023428#tab=citedBy
UR - https://www.mendeley.com/catalogue/0deda2ad-7b53-3dab-8f2c-f79a20343783/
U2 - 10.1093/JNCI/DJZ103
DO - 10.1093/JNCI/DJZ103
M3 - Review article
C2 - 31127946
SN - 0027-8874
VL - 111
SP - 1263
EP - 1278
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 12
ER -